12.04.2017
Drägerwerk AG & Co. KGaA DE0005550602
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Dräger closes the first quarter with a considerable improvement in earnings
DGAP-Ad-hoc: Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results
Drägerwerk AG & Co. KGaA: Dräger closes the first quarter with a
considerable improvement in earnings
12-Apr-2017 / 18:07 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Dräger closes the first quarter with a
considerable improvement in earnings
Dräger announces preliminary figures for the first quarter 2017.
Order intake in the first quarter rose by roughly 5.4 percent net of
currency effects (nominal 6.6 percent) compared to the first quarter last
year. Net sales declined by roughly 1.1 percent net of currency effects
(nominal increase 0.5 percent) to approximately EUR 535 million. The gross
profit margin stood at approximately 45 percent (Q1 2016: 42.0 percent).
Functional expenses declined by 1.9 percent net of currency effects (nominal
-0.7 percent). EBIT for the first quarter amounted to roughly EUR 2 million
and significantly exceeded the low EBIT of the prior year's quarter (Q1
2016: EUR -15,7 million).
Order intake rose in all regions. Demand increase in Europe was particularly
strong. In the region Americas, order growth was driven by the demand in
North America. Business development was challenging in Central- and South
America. Due to the positive development in China, order intake in the
region Africa, Asia, and Australia increased slightly.
The outlook for fiscal year 2017 remains unchanged. For the full year
Draeger continues to expect net sales growth (net of currency effects) of
between 0.0 and 3.0 percent and an EBIT margin of between 5.0 and 7.0
percent.
Dräger will publish final results for the first three months of 2017 on May
4, 2017.
Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck, Deutschland
www.draeger.com
Investor Relations:
Thomas Fischler
Tel. +49 451 882-2685
[email protected]
Corporate Communications:
Melanie Kamann
Tel. +49 451 882-3998
[email protected]
Disclaimer
This ad hoc report contains statements on the future development of Dräger
Group. These forward-looking statements are based on the current
expectations, presumptions, and forecasts of the Executive Board as well as
the information available to date. They were compiled to the best of the
company's knowledge. Dräger does not provide any warranty nor assume any
responsibility for the future developments and results described above.
These are dependent on a number of factors. They entail various risks and
contingencies outside of the company's influence and are based on
assumptions which could prove to be incorrect. Dräger does not assume any
responsibility for updating the forward-looking statements contained in this
report. This does not infringe any legal stipulations on the adjustment of
forecasts. Please go to Investor Relations / Financial Calendar at
www.draeger.com for information on all important financial dates.
---------------------------------------------------------------------------
12-Apr-2017 CET/CEST The DGAP Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23542 Lübeck
Germany
Phone: +49 (0)451 882-0
Fax: +49 (0)451 882-2080
E-mail: [email protected]
Internet: www.draeger.com
ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 065 1, DE 000
555 067 7, DE 000 555 071 9
WKN: 555060, 555063 Vorzüge, 555065 Genussschein A, 555067
Genussschein K, 555071 Genussschein D
Indices: TecDAX
Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime
Standard), Hamburg, Hanover, Munich; Regulated Unofficial
Market in Stuttgart, Tradegate Exchange
End of Announcement DGAP News Service
---------------------------------------------------------------------------
564687 12-Apr-2017 CET/CEST
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
Drägerwerk AG & Co. KGaA ISIN: DE0005550602 können Sie bei EQS abrufen
Medtech , 555060 , DRW8 , XETR:DRW8